I think this statement represents what happens with a great many microcap biotechs that are speculative at best.
The main thing of consequence that changed is the price. That matters mostly to traders. An investor who understood the risk factors could have already bought their fill below 60 cents.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.